Detalhe da pesquisa
1.
Significance of the autoantibody assay in predicting the development of immune-related adverse events in patients receiving atezolizumab plus bevacizumab combination therapy for unresectable hepatocellular carcinoma.
Hepatol Res
; 54(2): 162-173, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37740643
2.
Prediction of Therapeutic Response Using Contrast-Enhanced Ultrasound in Japanese Patients Treated with Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma.
Oncology
; 101(3): 173-184, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36516803
3.
Relationship between Plasma IP-10/CXCL10 Levels and the Initial Therapeutic Response in Patients Treated with Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma.
Oncology
; 101(10): 655-663, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379802
4.
Impact of Renal Function on the Prognosis of Patients Receiving Atezolizumab/Bevacizumab Combination Therapy and Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma.
Oncology
; 101(10): 609-623, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279708
5.
Significance of serum IP-10/CXCL10 measurement in predicting post-direct acting antiviral treatment liver function in patients with HCV-decompensated liver cirrhosis.
Hepatol Res
; 53(4): 280-288, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36445119
6.
Early diagnosis of hepatic inflammation in Japanese nonalcoholic fatty liver disease patients using 3D MR elastography.
Hepatol Res
; 53(3): 208-218, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36372908
7.
Effect of a combination of pemafibrate and a mild low-carbohydrate diet on obese and non-obese patients with metabolic-associated fatty liver disease.
J Gastroenterol Hepatol
; 38(6): 921-929, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36811251
8.
Plasma Renin Activity Predicts Prognosis and Liver Disease-Related Events in Liver Cirrhosis Patients with Ascites Treated by Tolvaptan.
Dig Dis
; 40(4): 479-488, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348262
9.
Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment.
J Viral Hepat
; 28(5): 787-794, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33484033
10.
Changes of liver stiffness measured by magnetic resonance elastography during direct-acting antivirals treatment in patients with chronic hepatitis C.
J Med Virol
; 93(6): 3744-3751, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32890408
11.
Prognosis of intrahepatic cholangiocarcinoma stratified by albumin-bilirubin grade.
Hepatol Res
; 51(8): 902-908, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34046984
12.
Hepatitis B core-related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen-negative chronic hepatitis B patients.
J Gastroenterol Hepatol
; 36(10): 2943-2951, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34057248
13.
Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease.
J Gastroenterol Hepatol
; 36(10): 2960-2966, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34154037
14.
Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis B.
J Med Virol
; 92(8): 1355-1358, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31994737
15.
Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis.
Hepatol Res
; 50(8): 996-999, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32515534
16.
Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis.
Hepatol Res
; 50(12): 1375-1385, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32924266
17.
Three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinib.
Hepatol Res
; 50(1): 137-143, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31349377
18.
Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analog.
J Gastroenterol Hepatol
; 35(9): 1595-1601, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31975419
19.
Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup.
Int J Mol Sci
; 22(1)2020 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33375190
20.
Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein but not α-fetoprotein as a Long-Term Hepatocellular Carcinoma Predictor.
Int J Mol Sci
; 21(10)2020 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32455631